Authors:
Hoyer-Hansen, G
Pessara, U
Holm, A
Pass, J
Weidle, U
Dano, K
Behrendt, N
Citation: G. Hoyer-hansen et al., Urokinase-catalysed cleavage of the urokinase receptor requires an intact glycolipid anchor, BIOCHEM J, 358, 2001, pp. 673-679
Authors:
Solberg, H
Ploug, M
Hoyer-Hansen, G
Nielsen, BS
Lund, LR
Citation: H. Solberg et al., The murine receptor for urokinase-type plasminogen activator is primarily expressed in tissues actively undergoing remodeling, J HIST CYTO, 49(2), 2001, pp. 237-246
Authors:
Pedersen, TL
Plesner, T
Horn, T
Hoyer-Hansen, G
Sorensen, S
Hansen, NE
Citation: Tl. Pedersen et al., Subcellular distribution of urokinase and urokinase receptor in human neutrophils determined by immunoelectron microscopy, ULTRA PATH, 24(3), 2000, pp. 175-182
Authors:
Gardsvoll, H
Solberg, H
Dano, K
Hoyer-Hansen, G
Citation: H. Gardsvoll et al., Generation of high-affinity rabbit polyclonal antibodies to the murine urokinase receptor using DNA immunization, J IMMUNOL M, 234(1-2), 2000, pp. 107-116
Authors:
Hedberg, KK
Stauff, C
Hoyer-Hansen, G
Ronne, E
Griffith, OH
Citation: Kk. Hedberg et al., High-molecular-weight serum protein complexes differentially promote cell migration and the focal adhesion localization of the urokinase receptor in human glioma cells, EXP CELL RE, 257(1), 2000, pp. 67-81
Authors:
List, K
Hoyer-Hansen, G
Ronne, E
Dano, K
Behrendt, N
Citation: K. List et al., Different mechanisms are involved in the antibody mediated inhibition of ligand binding to the urokinase receptor: a study based on biosensor technology, J IMMUNOL M, 222(1-2), 1999, pp. 125-133
Authors:
Pedersen, AN
Brunner, N
Hoyer-Hansen, G
Hamer, P
Jarosz, D
Larsen, B
Nielsen, HJ
Stephens, RW
Citation: An. Pedersen et al., Determination of the complex between urokinase and its type-I inhibitor inplasma from healthy donors and breast cancer patients, CLIN CHEM, 45(8), 1999, pp. 1206-1213
Authors:
Pedersen, AN
Brunner, N
Hoyer-Hansen, G
Hamer, P
Jarosz, D
Larsen, B
Nielsen, HJ
Stephens, RW
Citation: An. Pedersen et al., Determination of the complex between urokinase and its type-1 inhibitor inplasma from healthy donors and breast cancer patients (vol 45, pg 1206, 1999), CLIN CHEM, 45(11), 1999, pp. 2046-2046
Authors:
Holten-Andersen, MN
Murphy, G
Nielsen, HJ
Pedersen, AN
Christensen, IJ
Hoyer-Hansen, G
Brunner, N
Stephens, RW
Citation: Mn. Holten-andersen et al., Quantitation of TIMP-1 in plasma of healthy blood donors and patients withadvanced cancer, BR J CANC, 80(3-4), 1999, pp. 495-503